Share this article
Share this article has undergone multiple quantitative tests that demonstrate its filtration system effectively blocks passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19. This would effectively mitigate cross-contamination and transmission of infectious aerosols. The filtration found in Thopaz+ can help provide a safeguard for patients and staff.
(PRNewsfoto/Medela LLC) We understand the critical need for a solution like Thopaz+ that can help healthcare professionals provide safer cardiothoracic drainage and reduce cross contamination as well as healthcare-associated infections (HAI), during the COVID-19 pandemic and beyond, said Melissa Gonzales, RN, BSN, executive vice president of Medela Americas. With its intuitive, easy-to-use design and filtration capabilities, Thopaz+ was developed to meet the evolving needs of healthcare professionals and patients, simplify use while improving health outcomes and reduce co